The combination therapy of lenalidomide plus PD-1/PD-L1 inhibitors increased interferon γ by BM-derived effector cells in MM and was associated with increased apoptosis of MM cells, suggesting synergistic cytotoxic effects [56, 61, 62]. Here, PDCD1 is linked to Miyoshi myopathy.